Evaluation of Depression and Anxiety in Rheumatoid Arthritis Patients During COVID-19 Pandemic.
Dina M Abd El-KhalikMohamed EltohamyPublished in: Clinical medicine insights. Arthritis and musculoskeletal disorders (2023)
It was observed that patients diagnosed with RA revealed a higher prevalence of COVID-19 infection. The occurrence of depression and anxiety was observed to be widespread among patients diagnosed with RA and, more significantly, prevalent in RA patients who had a recent COVID-19 and had a higher level of disease activity. The occurrence of COVID-19 and disease duration were identified as factors that can anticipate the development of depression and anxiety.
Keyphrases
- disease activity
- rheumatoid arthritis patients
- rheumatoid arthritis
- systemic lupus erythematosus
- ankylosing spondylitis
- coronavirus disease
- sars cov
- juvenile idiopathic arthritis
- end stage renal disease
- risk assessment
- chronic kidney disease
- newly diagnosed
- ejection fraction
- interstitial lung disease
- patient reported outcomes
- patient reported
- idiopathic pulmonary fibrosis